Stereotaxis (STXS) Change in Accured Expenses (2010 - 2026)
Stereotaxis (STXS) reported Change in Accured Expenses of -$587000.0 for Q1 2026, down 11840.0% year-over-year from N/an in Q1 2025, and down 717.89% quarter-over-quarter from $95000.0 in Q4 2025.
Stereotaxis (STXS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Change in Accured Expenses data on file, last reported at -$587000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$587000.0, down 11840.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$404000.0 (down 143.37% YoY), and the FY2025 annual result was $188000.0, up 795.24% from the prior year.
- Change in Accured Expenses declined to -$587000.0 in Q1 2026 per STXS's latest filing, from $95000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $768000.0 in Q1 2023 and troughed at -$776000.0 in Q2 2023.
- A 5-year average of -$65266.7 and a median of -$17000.0 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 12500.0% in 2022, then surged 4617.65% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at -$248000.0 in 2022, then plunged by 31.45% to -$326000.0 in 2023, then dropped by 5.21% to -$343000.0 in 2024, then surged by 127.7% to $95000.0 in 2025, then slumped by 717.89% to -$587000.0 in 2026.
- Business Quant data shows STXS's Change in Accured Expenses at -$587000.0 in Q1 2026, $95000.0 in Q4 2025, and $238000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | -587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -587,000.00 |
| Mar 31, 2026 | -587,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Jun 30, 2024 | -181,000.00 |
| Jun 30, 2024 | -181,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Dec 31, 2023 | -326,000.00 |
| Dec 31, 2023 | -326,000.00 |